VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 365 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2016. The put-call ratio across all filers is 0.92 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $266,000 | +6.8% | 10,836 | -12.4% | 0.02% | +4.5% |
Q2 2016 | $249,000 | -26.5% | 12,374 | -4.1% | 0.02% | +37.5% |
Q1 2016 | $339,000 | -97.5% | 12,899 | -81.4% | 0.02% | -97.1% |
Q1 2015 | $13,808,000 | -82.7% | 69,520 | -88.6% | 0.54% | -82.2% |
Q3 2014 | $79,778,000 | -47.3% | 608,065 | -49.3% | 3.07% | -58.6% |
Q2 2014 | $151,283,000 | – | 1,199,511 | – | 7.40% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |